Related Experiment Video
Updated: May 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Method to determine allocation of clinical pharmacist resources
Robert P Granko1, Lindsey B Poppe, Scott W Savage
1UNC Hospitals, Department of Pharmacy, University of North Carolina, 101 Manning Drive, CB #7600, Chapel Hill, NC 27514, USA. rgranko@unch.unc.edu
This study introduces a new method to help hospital pharmacy departments decide where to place clinical pharmacist specialists (CPS). The method uses data like patient numbers, drug costs, and use of high-risk medications to calculate a score for each hospital service. Based on these scores, the study found that oncology, bone marrow transplant, and intensive care units need more CPS involvement. The tool was used to check current staffing and plan for new CPS positions. The approach provides an objective way to make staffing decisions in hospital pharmacy departments.
Area of Science:
- Pharmacy resource allocation in healthcare
- Clinical pharmacy practice within hospital systems
- Health services research in hospital pharmacy
Background:
Hospital pharmacy departments often face challenges in allocating clinical pharmacist resources efficiently. Prior research has shown that subjective decisions may lead to suboptimal staffing. This gap motivated the need for an objective framework. Existing knowledge includes general staffing models, but no prior work had resolved how to integrate patient census and medication data into a decision-making tool. The medical center's need for a structured approach led to the development of a novel methodology. The lack of a standardized allocation system for clinical pharmacist specialists (CPS) created uncertainty in resource planning. This paper's contribution lies in introducing a data-driven method to guide CPS deployment. The approach aims to improve the precision of staffing decisions in hospital settings.
Purpose Of The Study:
The study aimed to develop an objective methodology for allocating clinical pharmacist resources in a hospital setting. The specific problem addressed was the lack of a standardized system for deploying CPS staff. The motivation stemmed from the need to align staffing with patient care demands. The task force sought to evaluate the relative need for CPS expertise across hospital services. The goal was to identify metrics that best reflect the impact of CPS involvement. The methodology was designed to incorporate patient census and medication data. The approach was intended to support both existing and future staffing decisions. The study focused on creating a reproducible tool for pharmacy resource allocation.
Main Methods:
The task force analyzed patient census and medication-use data over several years. Proprietary databases from Thomson Reuters were used to calculate pharmacy intensity scores. The study evaluated five metrics relevant to pharmacy coverage. These metrics included patient acuity, drug expenditures, and high-risk medication use. The methodology was applied to assess the need for CPS expertise in various services. The approach considered teaching involvement and service-specific data. The task force used the metrics to determine optimal CPS placement. The methodology was tested across multiple hospital units to validate its applicability.
Main Results:
The methodology identified oncology, bone marrow transplant, and intensive care units as high-priority areas. These services showed the highest pharmacy intensity scores. The tool confirmed the existing allocation of CPS staff in these units. The approach was used to guide budgeting for new CPS positions. The metrics included patient census and drug expenditures. The model incorporated the use of high-risk medications as a key factor. The tool was validated through its application in multiple hospital services. The results supported the use of the methodology for future staffing decisions.
Conclusions:
The authors propose that the developed tool can guide the allocation of clinical pharmacist resources. The methodology provides an objective framework for CPS deployment. The tool incorporates patient census and medication data into staffing decisions. The findings suggest that oncology and intensive care units require higher CPS involvement. The approach was validated through its use in existing and new staffing scenarios. The study supports the use of data-driven metrics for resource allocation. The tool can be adapted for use in other hospital settings with similar models. The authors suggest that the methodology improves the precision of staffing decisions.
Frequently Asked Questions
The methodology uses patient census, drug expenditures, and high-risk medication data to determine the optimal allocation of clinical pharmacist resources.
The study used five metrics: patient census, patient acuity, teaching involvement, drug expenditures, and use of high-risk medications.
High-risk medications are associated with greater clinical oversight needs, making them a critical factor in determining the need for CPS expertise.
Proprietary databases from Thomson Reuters were used to calculate service-specific pharmacy intensity scores, which informed staffing decisions.
The methodology was used to validate existing staffing and guide budgeting for new clinical pharmacist specialist positions in high-need hospital services.
The authors suggest that the methodology improves the precision of staffing decisions for clinical pharmacist specialists in hospital settings.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Measurement of Bioavailability: Pharmacodynamic Methods
Dosage Interval and Administration Route: Determination Methods
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...

